Bruxelles le 8 novembre 2007
Désolé. Actuellement, cette page n'existe pas en français.
A conference organised by the European Patent Office
8 November 2007, the Stanhope Hotel, Brussels
Nearly ten years have passed since the adoption of the European directive on the legal protection of biotechnological inventions. What is the situation today with regard to the patentability of inventions relating to stem cells, genes or plants? What developments have occurred in legislation and patent office practice in Europe, and how have the changes affected the patenting strategies of applicants? What questions remain to be clarified, and how does the EPO address the practical issues in this area?
To provide up-to-date information and facilitate an open exchange of ideas, the EPO is organising a free conference on this topic. The speakers will include political decision-makers, representatives of society and patent experts.
In 1998 the European legislator adopted the Directive 98/44 EC for the legal protection of biotechnological inventions with a view to harmonising the patenting practice in this field. The Directive also forms a part of the EPO's legal body, the EPC, and is the basis for the Office's examination practice.
As technology advances and new challenges in science, ethics and politics arise, biotechnology patents continue to be in the focus of public attention. This conference seeks to assess the situation as it presents itself today from a political and technical perspective: What has been achieved since the directive entered into force? Which ones are the gains and unresolved issues? How does the picture present itself in areas of particular interest, such as DNA sequences, green biotechnology and human embryonic stem cells?
These questions will be addressed in four dedicated panels with expert speakers from the fields of politics, business, civil society and intellectual property. Regular updates on topics and speakers are published on the EPO's website at
The conference addresses policy makers having an interest in intellectual property matters in European and national institutions, enterprises, special interest and civil society groups, and journalists.
The conference language is English.
Participation at the conference is free of charge. Please register at press@epo.org citing "Biotechnology Conference" in the subject line.
For all queries concerning further information please contact the press desk of the EPO:
Rainer Osterwalder
+4989-23991820 or +49163-8399527 (m)
rosterwalder@epo.org
Danielle Wagner
+4989-23991821
dwagner@epo.org
Paul Meller
European Affairs Correspondent
Science Business magazine
Rainer Osterwalder
Director for Media Relations
European Patent Office
| Time | Programme |
|---|---|
| 09.00 - 10.00 |
Welcome coffee and registration
|
| 10.00 - 12.00 |
Panel 1: Progress or stagnancy
Sharon Bowles
Ingwer Koch
(PDF, 231 KB)
Prof. Julian Kinderlerer
Johan Vanhemelrijk
Christoph Then
(PDF, 2.7 MB) |
| 12.00 - 12.30 |
Discussions with the floor |
| 12.30 - 14.00 |
Lunch
|
| 14.00 - 15.00 |
Panel 2: DNA patents
Jacques Warcoin
(PDF, 171 KB)
Michael Hopkins
(PDF, 159 KB)
Sven Bostyn
(PDF, 205 KB)
|
| 15.00 - 16.00 |
Panel 3: Plants and animals - new challenges
Ralf Badur
(PDF, 296 KB)
Pierre Roger
(PDF, 32 KB)
Aliki Nichogiannopoulou
(PDF, 815 KB)
|
| 16.00 - 16.15 |
Coffee break
|
| 16.15 - 17.15 |
Panel 4: Stem cell patents - a road ahead?
Pierre Treichel
(PDF, 137)
Nick Bassil
(PDF, 51 KB)
Julian Kinderlerer
|
| 17.15 - 17.30 |
Summary and closure
|